Assignee
BRAHMS GMBH
DE43 patents
Top patents by PatentIndex Score
US8354506B2Jan 15, 2013
Antibodies for the selective determination of procalcitonin 1-116
BRAHMS GMBH21 citations93
US7972799B2Jul 5, 2011
Method for determining sepsis using pro-ADM
BRAHMS GMBH14 citations92
US9541549B2Jan 10, 2017
Determination of a midregional proadrenomedullin partial peptide in biological fluids for diagnostic purposes, and immunoassays for carrying out such a determination
BRAHMS GMBH9 citations84
US7977072B2Jul 12, 2011
Sandwich immunoassay for identifying partial proANP peptides
BRAHMS GMBH10 citations84
US7915002B2Mar 29, 2011
Method for controlling the therapy of patients suffering from cardiac insufficiency by means of in vitro determination of threshold values of vasoactive peptides
BRAHMS GMBH17 citations84
US8013123B2Sep 6, 2011
Use of precursors of enkephalins and/or their fragments in medical diagnostics
BRAHMS GMBH9 citations83
US9753039B2Sep 5, 2017
Prognosis of adverse events in patients with suspected chronic heart failure
BRAHMS GMBH6 citations76
US11241395B2Feb 8, 2022
Use of procalcitonin (PCT) in risk stratification and prognosis of patients with a primary, non-infectious disease
BRAHMS GMBH2 citations73
US7998686B2Aug 16, 2011
Method for determining sepsis using pro-BNP
BRAHMS GMBH4 citations73
US8383332B2Feb 26, 2013
Procalcitonin for the diagnosis of bacterial infections and guidance of antibiotic treatment in patients with acute stroke or transient ischemic attack
BRAHMS GMBH5 citations69
US10954298B2Mar 23, 2021
Method of obtaining a binder to prepro-vasopressin or fragments thereof
BRAHMS GMBH0 citations63
US8853355B2Oct 7, 2014
Diagnosis and risk stratification by determining the marker CT-proADM
BRAHMS GMBH1 citations63
US12153057B2Nov 26, 2024
Antibiotic therapy guidance based on procalcitonin in patients with comorbidities
BRAHMS GMBH0 citations59
US9513301B2Dec 6, 2016
Method for risk stratification in stable coronary artery disease
BRAHMS GMBH2 citations59
US12405279B2Sep 2, 2025
Method for preparing a sample
BRAHMS GMBH0 citations57
US12000845B2Jun 4, 2024
Method for discharging a patient from an intensive care unit
BRAHMS GMBH0 citations57
US11327082B2May 10, 2022
Proadrenomedullin as a marker for abnormal platelet levels
BRAHMS GMBH0 citations57
US11041867B2Jun 22, 2021
ProADM and/or histones as markers indicating an adverse event
BRAHMS GMBH2 citations56
US11835531B2Dec 5, 2023
Procalcitonin for the prognosis of adverse events
BRAHMS GMBH0 citations53
US10048280B2Aug 14, 2018
Immunoassay for the detection of procalcitonin
BRAHMS GMBH1 citations52
US9810699B2Nov 7, 2017
Risk assessment for antibiotics treatment in patients suffering from primary non-infectious disease by determining the level of procalcitonin
BRAHMS GMBH0 citations52
US9726675B2Aug 8, 2017
Diagnosis and risk stratification by determining the marker CT-proADM
BRAHMS GMBH0 citations52
US9664689B2May 30, 2017
Method for the selective detection and measurement of procalcitonin 1-116 and amino-terminal peptides of procalcitonin comprising amino acids 1 and 2 of procalcitonin 1-116
BRAHMS GMBH1 citations52
US10718783B2Jul 21, 2020
Diagnosis and risk stratification of infections and chronic diseases of the respiratory tract and lungs by means of provasopressin, particularly copeptin or neurophysin II
BRAHMS GMBH0 citations51
US10067063B2Sep 4, 2018
Prognosis and risk assessment in stroke patients by determining the level of marker peptides
BRAHMS GMBH1 citations51
US10254289B2Apr 9, 2019
In vitro method for early or differential diagnosis or prognosis of myocardial infarction in a patient
BRAHMS GMBH0 citations50
US9261517B2Feb 16, 2016
Diagnosis of acute coronary syndrome, myocardial infarction, or angina pectoris by means of neurophysin II
BRAHMS GMBH0 citations50
US11592450B2Feb 28, 2023
Diagnosis and risk stratification of fungal infections
BRAHMS GMBH0 citations49
US9952229B2Apr 24, 2018
Arginine vasopressin pro-hormone as predictive biomarker for diabetes
BRAHMS GMBH0 citations49
US9217742B2Dec 22, 2015
Method for risk stratification in stable coronary artery disease
BRAHMS GMBH0 citations49
US8029790B2Oct 4, 2011
Monoclonal thyroid stimulating or blocking antibodies, peptide sequences corresponding to their variable regions, and their uses in diagnostic, preventive and therapeutic medicine
BRAHMS GMBH0 citations49
US10857129B2Dec 8, 2020
V1B receptor antagonist for use in the treatment of patients having an elevated AVP level and/or an elevated copeptin level
BRAHMS GMBH0 citations48
US12181474B2Dec 31, 2024
Biomarkers for the diagnosis of invasive fungal infections
BRAHMS GMBH0 citations47
US12517138B2Jan 6, 2026
Method for guidance of fluid therapy based on proadrenomedullin
BRAHMS GMBH0 citations46
US12442825B2Oct 14, 2025
Prescription of remote patient management based on biomarkers
BRAHMS GMBH0 citations46
US12265092B2Apr 1, 2025
Workflow for risk assessment and patient management using procalcitonin and midregional-proadrenomedullin
BRAHMS GMBH0 citations45
US10921330B2Feb 16, 2021
Method for diagnosis of dementias and neuroinflammatory diseases based on an increased level of procalcitonin in cerebrospinal fluid
BRAHMS GMBH0 citations43
US9488659B2Nov 8, 2016
Prognosis of adverse events in patients with suspected chronic heart failure
BRAHMS GMBH1 citations43
US12385926B2Aug 12, 2025
MMP-8 as a marker for identifying infectious disease
BRAHMS GMBH0 citations42
US11402393B2Aug 2, 2022
Procalcitonin for the diagnosis of bacterial infections and guidance of antibiotic treatment in patients with non-specific complaints
BRAHMS GMBH0 citations39
US12560620B2Feb 24, 2026
Pro-ADM for prognosis of trauma-related complications in polytrauma patients
BRAHMS GMBH0 citations38
US10024872B2Jul 17, 2018
Augurin immunoassay
BRAHMS GMBH0 citations33
US11391742B2Jul 19, 2022
Free histone proteins as biomarkers
BRAHMS GMBH0 citations32